Decision letter for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):